Biotech 2050 Podcast cover image

Novel approach to targeted protein degradation, Nicki Thompson, CEO, Amphista Therapeutics

Biotech 2050 Podcast

00:00

Targeted Protein Degradation as a Treatment Modality

The first generation of the small molecule approaches for targeted protein degradation are known as bifunctional molecules. They have one end that engages the target that you would like to degrade or dispose of usually a disease causing protein. The other end of the molecule is part of the molecule that engages the machinery in the cell that basically takes the target protein that you want to degrade and destroys it essentially within the cell.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app